Highlights and Quick Summary
Current Net Cash/Marketcap of Design Therapeutics, Inc. is $-0.0672 (as of December 31, 2020)
- Net Cash/Marketcap for the quarter ending December 31, 2020 was $-0.0672 (a -0.0% decrease compared to previous quarter)
- Year-over-year quarterly Net Cash/Marketcap decreased by -0.0%
- Annual Net Cash/Marketcap for 2020 was $-0.0672
Visit stockrow.com/DSGN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Cash/Marketcap of Design Therapeutics, Inc.
Most recent Net Cash/Marketcapof DSGN including historical data for past 10 years.Interactive Chart of Net Cash/Marketcap of Design Therapeutics, Inc.
Design Therapeutics, Inc. Net Cash/Marketcap for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2020 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
Business Profile of Design Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology